Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Real World Evidence: Between 'Nirvana' And Electronic Roadblocks

Executive Summary

US FDA's Jonathan Jarow says it will be up to pharma industry to get right data into electronic health records.

You may also be interested in...



Independence, But Not Isolation: Panel Of FDA Commissioners Reflect On Role Of Dialogue With External Stakeholders

US FDA Commissioner Scott Gottlieb and three former agency heads tout value of deliberation with broader scientific community, but also agency's ability to make regulatory decisions independently.

US FDA Officials Provide Primer On 'Real-World' Data

In a journal article, Center for Drug Evaluation and Research Director Janet Woodcock and colleagues describe the sources of real-word evidence and study designs that can be used to generate such evidence.

When Will Real World Evidence Be Persuasive? FDA's Temple Offers Perspective

Postmarketing studies randomized to look at real world data sets could provide the key, Temple suggests; Amgen rep describes use of real world data to support approval of leukemia drug Blincyto.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

ID034708

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel